A single-institution experience with the Optilume Urethral Drug Coated Balloon for management of urethral stricture disease.

ABSTRACT:

Background

Urethral stricture disease is detrimental to quality of life. The Optilume Urethral Drug Coated Balloon (DCB) offers a solution utilizing a paclitaxel-coated balloon to expand strictures and prevent recurrence. Following the ROBUST trials, it has been proposed that DCB is more effective than conventional endoscopic management for recurrent, small anterior urethral strictures. Our study provides insights into practical applications and outcomes using DCB for urethral stricture disease.

Methods

A retrospective review was performed of patients who underwent DCB for urethral strictures at our institution from November 2022 to August 2023 with follow-up evaluated through January 2024. Demographics, stricture characteristics, operative details, and postoperative outcome

SUBMITTER: Mahenthiran AK 

PROVIDER: S-EPMC11399038 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature